Hira Rizvi - 7 Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 175 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell Lung Cancer

Federica Pecci,Rohit Thummalapalli, Stephanie L Alden,Biagio Ricciuti, Joao V Alessi,Arielle Elkrief,Hira Rizvi, Xinan Wang, Mark Jeng,Jacklynn V Egger, Victor R Vaz,Adriana Barrichello,Giuseppe Lamberti,Alessandro Di Federico, Valentina Santo, Guilherme Rossato de Almeida,Malini Gandhi, Phoebe Clark,Mizuki Nishino, Bruce E Johnson,Matthew Hellmann,Adam J Schoenfeld, Mark M Awad

Clinical cancer research an official journal of the American Association for Cancer Research（2025）

Cited0Views0WOSBibtex

Supplemental Figure 1 from Response to Standard Therapies and Comprehensive Genomic Analysis for Patients with Lung Adenocarcinoma with EGFR Exon 20 Insertions

Noura J. Choudhury,Adam J. Schoenfeld, Jessica Flynn,Christina J. Falcon,Hira Rizvi,Charles M. Rudin,Mark G. Kris,Maria E. Arcila,Glenn Heller,Helena A. Yu,Marc Ladanyi, Gregory J. Riely

openalex（2023）

Cited0Views0Bibtex

The Ectonucleotidase CD39 Identifies Tumor-Reactive CD8+ T Cells Predictive of Immune Checkpoint Blockade Efficacy in Human Lung Cancer

IMMUNITYno. 1 (2023): 93-+

Cited45Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn